There is a growing suspicion that conventional imaging understages many presumed early-stage lobular cancers. Using FES PET-CT upfront could detect small-volume metastatic disease missed by other methods. This would reclassify patients to a metastatic setting, sparing them the morbidity of major local surgeries that would not be curative.

Cervical cancer is one of the few malignancies where clinical staging via physical examination remains paramount. Advanced imaging like MRI or PET scans can sometimes overestimate the extent of the disease, making a hands-on clinical exam essential for accurate staging and treatment planning.

Histosonics is pioneering the next stage of surgery by using focused sound waves to non-invasively liquefy tumors. This breakthrough technology can treat patients previously deemed non-surgical candidates, improving their condition enough to make them eligible for surgical resection or even organ transplants, creating entirely new therapeutic pathways.

The next wave of MedTech innovation won't just come from engineers. It will come from creating tools that allow surgeons and clinicians—those who see problems firsthand—to easily prototype and de-risk new device concepts, vastly expanding the market for innovation itself.

The path to printing whole organs is being de-risked through intermediate, commercially viable applications. Companies are already generating value by printing brain tissues for R&D (e.g., for Neuralink) and simpler structures like blood vessels for surgery, proving the technology incrementally.

Fluorescence-guided surgery will evolve beyond simply lighting up tumors. Dr. Phil Low's team is developing different colored dyes to simultaneously highlight healthy, critical structures like nerves and ureters. This 'surgery by colors' approach aims to prevent accidental severing and reduce major complications like incontinence or impotence.

AI is improving medical imaging accuracy and speed by nearly 70%, enabling earlier detection of chronic diseases. This leads to more effective preventive care, which is crucial for an aging global population and offers a promising path to making overall healthcare more cost-effective.

Surgeons perform intricate tasks without tactile feedback, relying on visual cues of tissue deformation. This suggests robotics could achieve complex manipulation by advancing visual interpretation of physical interactions, bypassing the immense difficulty of creating and integrating artificial touch sensors.

Top surgeons transition from clinical practice to corporate roles for the opportunity to leverage technology and scale their impact on patient lives far beyond what's possible in a single operating room.